PlainBillCongress, translated.Legislation. Context. Public interest.Sponsor introductory remarks on measure. (CR H3663)
Congressional Research Service
Version 00 · Introduced in House · Oct 28, 2003
Dietary Supplement Access and Awareness Act - Amends the Federal Food, Drug, and Cosmetic Act to require reports to the Secretary of Health and Human Services by: (1) manufacturers and processors of dietary supplements respecting dietary supplement product listing (including labeling, ingredient, and discontinuance information); and (2) manufacturers and distributors of dietary supplements respecting serious adverse experiences resulting from a supplement's use (requires manufacturer or distributor investigation of such occurrence).
Authorizes the Secretary to require a manufacturer to: (1) provide postmarket surveillance if there is a reasonable possibility of a supplement causing adverse health consequences; and (2) demonstrate that a supplement is not adulterated if the Secretary has reasonable grounds for believing that a supplement may be adulterated (permits distribution during such demonstration period unless determined to be an imminent public health hazard, and requires a final determination of adulteration by the Secretary). Deems a supplement as adulterated for noncompliance with such safety demonstration provisions.
Authorizes the Secretary to make a determination that a dietary supplement may pose a significant risk to individuals under the age of 18, and prohibit (as misbranded while held for sale) the supplement's sale to such individuals.
Showing the opening paragraphs of the official summary.
Includes among prohibited acts failure to comply with the requirements added by this Act (other than safety demonstration requirements). Extends inspection authority to records, controls, and facilities related to a determination of supplement adulteration.
Directs the Secretary to carry out dietary supplement education programs for health care professionals and consumers.
People & committees
Rep. Davis, Susan A. [D-CA-53] · D–CA
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Sponsor introductory remarks on measure. (CR H3663)
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Sponsor introductory remarks on measure. (CR E2150)
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 18, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.3377 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.3377 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.3377 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.3377 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.